Our study also clearly demonstrated that PAC and cisplatin arrested oral cancer cell proliferation by destabilizing cell-cycle distributions, downregulating the expression of cyclin D1, and upregulating of cyclin-dependent kinase inhibitors, such as the p21 gene, as observed in our previous work with the single treatment with PAC [19]. Here, CCND1 is linked to lip and oral cavity carcinoma.